Skip to content

Clinical trials

Anemia, Refractory, with Excess of Blasts trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Country / region: Canada Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20051
20061
20071
20092
20122
20141
20151
20191
20202
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting5
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
Children's Oncology Group2
University Health Network, Toronto2
CASI pharmaceuticals, Inc.1
Celgene1
Genzyme, a Sanofi Company1
McMaster University1
Novartis Pharmaceuticals1
Ottawa Hospital Research Institute1
SWOG Cancer Research Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts17
Myelodysplastic Syndromes13
Leukemia, Myelomonocytic, Chronic6
Leukemia5
Anemia, Refractory4
Leukemia, Myeloid, Acute4
Myeloproliferative Disorders4
Hematologic Neoplasms3
Hodgkin Disease3
Leukemia, Lymphocytic, Chronic, B-Cell3

Trials

Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.